Text: Forbes China.
On the evening of January 9, iFLYTEK issued an announcement announcing its plan to spin off its subsidiary iFLYTEK Medical to be listed on the Hong Kong Stock Exchange. After the completion of the spin-off, iFLYTEK Medical will obtain financing through the Hong Kong capital market, and after the completion of the spin-off, iFLYTEK will still maintain control of iFLYTEK Medical.
Founded in May 2016, with the mission of creating "AI diagnosis and treatment assistant for every doctor and AI health assistant for everyone", iFLYTEK Medical has built an artificial intelligence medical solution system based on the world's leading core technologies such as medical semantic computing, text understanding, knowledge reasoning, and data mining, aiming at the wide range of medical industry practitioners such as primary medical institutions, hospitals, patients and residents, and realizing the medical process coverage from disease early warning, early screening, diagnosis, ** and efficacy evaluation, post-diagnosis and chronic disease management.
Financial data show that iFLYTEK Medical will achieve operating income of 3 in 2020, 2021 and 2022 respectively2.1 billion yuan, 35.6 billion and 49.4 billion yuan, and the net profit attributable to the parent company was 76.1 billion390,000 yuan, -7,973230,000 yuan and -20.4 billion yuan. iFLYTEK has 8 subsidiaries.
In 2023, the emergence of large-scale models will bring new development opportunities to the medical and health industry. On October 24 of the same year, the iFLYTEK Xinghuo medical model was officially launched. It is understood that the iFLYTEK Xinghuo medical model has been successfully applied to products such as the "iFLYTEK Xiaoyi APP", and will be further applied to artificial intelligence-assisted diagnosis scenarios such as "intelligent medical assistant" in the future to further improve the diagnosis and treatment capabilities of AI assistants.
According to the information released by iFLYTEK, as of December 2023, the "Intelligent Medical Assistant" has completed more than 700 million auxiliary diagnoses in 426 districts and counties in 31 provinces across the country, detected more than 5,400 unreasonable prescriptions, and corrected more than 1.33 million medical records after being reminded by the Intelligent Medical Assistant.
On the morning of January 10, iFLYTEK (00230) fought long and short, steadily upward, as of press time, the stock price was red, up slightly 022% to 40$25 shares.